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Abstract
Hematopoietic progenitors undergo differentiation while navigating several cell division cycles, but it is unknown whether
these two processes are coupled. We addressed this question by studying erythropoiesis in mouse fetal liver in vivo. We
found that the initial upregulation of cell surface CD71 identifies developmentally matched erythroblasts that are tightly
synchronized in S-phase. We show that DNA replication within this but not subsequent cycles is required for a
differentiation switch comprising rapid and simultaneous committal transitions whose precise timing was previously
unknown. These include the onset of erythropoietin dependence, activation of the erythroid master transcriptional
regulator GATA-1, and a switch to an active chromatin conformation at the b-globin locus. Specifically, S-phase progression
is required for the formation of DNase I hypersensitive sites and for DNA demethylation at this locus. Mechanistically, we
show that S-phase progression during this key committal step is dependent on downregulation of the cyclin-dependent
kinase p57KIP2 and in turn causes the downregulation of PU.1, an antagonist of GATA-1 function. These findings therefore
highlight a novel role for a cyclin-dependent kinase inhibitor in differentiation, distinct to their known function in cell cycle
exit. Furthermore, we show that a novel, mutual inhibition between PU.1 expression and S-phase progression provides a
‘‘synchromesh’’ mechanism that ‘‘locks’’ the erythroid differentiation program to the cell cycle clock, ensuring precise
coordination of critical differentiation events.
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Introduction
Hematopoietic progenitors execute a cell division program in
parallel with a differentiation program in which lineage choice is
followed by lineage-specific gene expression. In many differenti-
ation models, cell cycle exit, driven by cyclin-dependent kinase
inhibitors (CDKI), is a prerequisite for terminal differentiation,
establishing a key interaction between the cell cycle and differen-
tiation programs [1–3]. However, it is unclear how the cell cycle
and differentiation programs might be linked prior to cell cycle
exit. Such links are presumably required to ensure the correct
number of differentiated progeny. In addition, it has been
speculated that the reconfiguration of chromatin at sites of
lineage-specific genes, a necessary step preceding lineage-specific
gene expression, may be innately dependent on DNA replication
[4,5]. An intriguing possibility is that the clockwork-like mecha-
nisms regulating orderly cell cycle transitions may also be used, in
the context of differentiating cells, to coordinate key steps in
differentiation.
Here we studied differentiation of the enucleated red blood cell
lineage, which first arises from hematopoietic stem cells in the fetal
liver on embryonic day 11 (E11). It replaces a transient, nucleated
yolk-sac erythrocyte lineage and persists throughout life. Although
many of the committal events that lead to the erythroid phenotype
are known, their precise timing in erythroid differentiation, and
the manner in which they are coordinated with each other and/or
with the cell cycle machinery, is poorly understood. Thus, survival
of erythroid progenitors requires both the hormone erythropoietin
(Epo), and its receptor, EpoR, a class I cytokine receptor expressed
by erythroid progenitors [6]. However, the precise time in
erythroid differentiation when progenitors become dependent on
Epo had not been defined. The master transcriptional regulator
GATA-1 is responsible for the erythroid gene expression profile, in
combination with a number of additional transcriptional regula-
tors, including FOG-1, EKLF, SCL/Tal-1, LMO2, Ldb1, E2A,
and Zbtb7a [7–10]. Though GATA-1 functional activation must
precede erythroid gene induction, its precise timing in primary
differentiating progenitors is not known. GATA-1 functions are
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antagonized by PU.1, an Ets transcription factor that acts as a
master regulator in the myeloid and B-cell lineages. The mutual
inhibition between PU.1 and GATA-1 is thought to underlie cell
fate choice in multipotential progenitors [11–14]. PU.1 has been
implicated in erythroleukemia [13,15], but its physiological
function in erythropoiesis is not known.
Erythroid gene induction by GATA-1 requires an ‘‘open
chromatin’’ conformation in the vicinity of erythroid-specific genes.
The erythroid-specific b-globin locus is one of the best studied models
of lineage-specific gene expression [16,17]. The active locus is
characterized by early replication during S-phase, higher sensitivity to
DNase I digestion, low levels of DNA methylation, and post-
translational histone tail modifications associated with actively
transcribed genes. Conversely, the same locus in non-erythroid cells
is DNase I resistant, replicates late in S-phase, and contains histone
tail modifications characteristic of silent chromatin. In spite of the
detailed knowledge contrasting chromatin states in erythroid cells
with non-erythroid cells, the precise time during erythroid differen-
tiation when chromatin reconfiguration occurs is not known.
Furthermore, it is not known whether this reconfiguration involves
a number of sequential stepwise alterations occurring over a number
of cell cycles/differentiation stages or whether the many changes
entailed in chromatin activation occur simultaneously.
Here we studied erythroid differentiation using a flow-cytometric
assay that identifies sequential stages in erythroid differentiation
directly within primary hematopoietic tissue. We found that in
mouse fetal liver in vivo, upregulation of CD71 marks cells that are
synchronized in S-phase of a single cell cycle, corresponding to the
last generation of erythroid colony-forming cells, approximately
three cell cycles prior to terminal cell cycle exit. A number of
differentiation milestones, whose precise timing in erythroid
development was previously unknown, occur during early S-phase
of this cycle. These include the onset of Epo dependence, activation
of GATA-1 function, and the opening up of chromatin at the b-
globin locus. We show that S-phase progression during this specific
cell cycle is dependent on downregulation of p57KIP2 and is required
for execution of these differentiation milestones, including the
reconfiguration of chromatin at the b-globin locus. Further, this S-
phase dependent rapid differentiation transition is regulated by
PU.1 through a newly identified, mutual antagonism between S-
phase progression and PU.1 expression that coordinates the precise
locking of the differentiation program to the cell cycle clock as cells
enter a terminal differentiation phase.
Results
Upregulation of Cell-Surface CD71 Marks the Onset of
EpoR Dependence in Erythroid Progenitors
Mouse fetal liver between E11 and E15 is primarily an
erythropoietic tissue. Cell surface markers CD71 and Ter119 may
be used to identify differentiation-stage specific subsets, directly in
primary tissue [18–20]. Here we divided freshly harvested fetal liver
cells into six CD71/Ter119 subsets that we termed S0 to S5 and
that form a developmental sequence (Figure 1A). Cells isolated from
subsets S1 to S5 show morphological features characteristic of
erythroid maturation, including decreasing cell and nuclear size,
nuclear condensation, and hemoglobin expression (Figure 1A, right
panel). The precise proportion of fetal liver cells within each of the
CD71/Ter119 subsets is a function of embryonic age, with the
majority of cells being in the early, S0 and S1 subsets in E12. The
more mature, S3 to S5 subsets are gradually populated with cells
during subsequent embryonic days (E13 to E15) [20].
The EpoR2/2 fetal liver is small and lacks morphologically
identifiable hemoglobinized erythroblasts of the enucleated (defin-
itive) lineage [6]. Here we found that EpoR2/2 fetal liver does not
contain subsets S1 to S5 (Figure 1B). This suggested that in the
definitive erythropoietic lineage that gives rise to adult-type
enucleated red cells, EpoR becomes essential on or prior to the
transition from S0 to S1; subsets S1 to S5 are composed almost
entirely of Epo-dependent erythroblasts. Of note, the small number
(<5%) of Ter119+ cells in the EpoR2/2 fetal liver are all nucleated
erythrocytes of the transient yolk-sac (primitive) lineage (Figure S1A).
The Majority of S0 Cells Are Erythroid Progenitors at the
CFU-e Stage
Erythroid progenitors have traditionally been identified by their
in vitro colony-forming potential. ‘‘Colony forming unit-ery-
throid’’ (CFU-e) are defined as cells that give rise to colonies
containing 8 to 32 hemoglobinized cells after 2–3 days of in vitro
culture in Epo [21]. We investigated the colony-forming potential
of cells sorted from each of the S0 to S3 subsets (Figure 1C). CFU-
e potential was exclusive to S0 and S1 and was lost with the
transition to S2. Cells in S2 and S3 gave rise to small, 2 to 4 cell
clusters (Figure 1C, right panel).
The frequency of CFU-e obtained from sorted S0 cells was
65%–70% of the frequency from sorted S1 (Figure 1C). S1 consists
entirely of Epo-dependent cells of similar maturation, with CFU-e
potential (Figure 1A–C). Assuming similar plating efficiency for
sorted S0 and S1 (of<30%, Figure 1C), this suggested that CFU-e
make up 65%–70% of the S0 subset. This is in agreement with our
Author Summary
Hematopoietic progenitors that give rise to mature blood
cell types execute simultaneous programs of differentia-
tion and proliferation. One well-established link between
the cell cycle and differentiation programs takes place at
the end of terminal differentiation, when cell cycle exit is
brought about by the induction of cyclin -dependent
kinase inhibitors. It is unknown, however, whether the cell
cycle and differentiation programs are coordinated prior to
cell cycle exit. Here, we identify a novel and unique link
between the cell cycle clock and the erythroid (red blood
cell) differentiation program that takes place several cell
division cycles prior to cell cycle exit. It differs from the
established link in several respects. First, it takes place at
the onset, rather than at the end, of erythroid terminal
differentiation, preceding the chromatin changes that
enable induction of red cell genes. Second, it is initiated
by the suppression, rather than the induction, of a cyclin -
dependent kinase inhibitor. It therefore causes the cell to
enter S-phase, rather than exit the cell cycle. Specifically,
we found that there is an absolute interdependence
between S-phase progression at this time in differentia-
tion, and a key commitment step in which, within a short
few hours, cells become dependent on the hormone
erythropoietin, undergo activating changes in chromatin
of red cell genes, and activate GATA-1, the erythroid
master transcriptional regulator. Arresting S-phase pro-
gression at this time prevents execution of this commit-
ment step and subsequent induction of red cell genes;
conversely, arresting differentiation prevents S-phase
progression. However, once cells have undergone this
key commitment step, there is no longer an interdepen-
dence between S-phase progression and the induction of
erythroid genes. We identified two regulators that control
a ‘‘synchromesh’’ mechanism ensuring the precise locking
of the cell cycle clock to the erythroid differentiation
program during this key commitment step.
S-Phase Coordinates Erythroid Commitment
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Figure 1. Upregulation of CD71 coincides with the onset of EpoR dependence and with S-phase of the last generation of CFU-e. (A)
Fetal liver subsets S0 to S5 form an erythroid developmental sequence. Freshly isolated E14.5 fetal liver was mechanically dissociated and labeled for
cell-surface CD71 and Ter119. Cytospin preparations from each subset (right panel) were stained with Giemsa and diaminobenzidine. Scale bar = 20 m
(B) CD71/Ter119 profiles for E12.5 EpoR2/2 and wild-type littermate fetal livers. Erythroid differentiation of EpoR2/2 cells is blocked at the transition
from S0 to S1. Ter119+ cells in EpoR2/2 liver are nucleated yolk-sac erythrocytes (Figure S1A). Representative of more than four experiments. (C)
Erythroid and non-erythroid colony forming potential of fetal liver subsets. 100,000 cells sorted from each of S0 to S3 were plated in methylcellulose
in the presence of Epo, IL-3, SCF, and IL-6. Colonies were scored on days 3 (CFU-e) and 10 (CFU-GM). Data are mean 6 SE of three independent
experiments. Pictures of colonies on day 2 are shown (right panel, lens magnification 620 for all subsets). There was no statistically significant
difference between S0 and S1 (p=0.2, paired t test). (D) Non-erythroid lineage-marker expression in S0 to S5. Wild-type or EpoR2/2 fetal livers were
labeled with CD71 and Ter119 to identify subsets S0 to S5, and with a cocktail of non erythroid lineage markers containing Mac-1, Gr-1, CD41, B220,
and CD3, or with isotype control antibody. See also Figure S1B. (E) Representative cell cycle analysis for S0 to S5. Pregnant mice were injected with a
pulse of BrdU, and fetal livers were harvested 30 to 50 min post-injection. Cells from each of subsets S0 to S5 were sorted by flow-cytometry and
labeled for BrdU incorporation and DNA content (7AAD). (F) Summary of six independent cell cycle analysis experiments as described in (E). Data are
mean 6 SE. The difference between the number of S-phase cells in S0 and S1 is significant at p,0.0001 (paired t test). (G) Upper panel: Quantitative
RT-PCR analysis of mRNA expression for cyclins A2, B1, E1, E2, D2, and for p57KIP2. Data (mean 6 SE of three experiments) were normalized to b-actin
mRNA in each sample and expressed as S1/S0 fold change (no change= 0). Fold changes are indicated. Lower panel: p57KIP2 protein in sorted S0, S1,
and S2+3 subsets. Quantitative western blotting with antibodies directed at p57KIP2 and b-actin; Near infra-red (NIR) fluorescence–conjugated
secondary antibodies. S0 cell transduced with retroviral vector encoding either p57T329A-ICD4 or empty vector (MICD4) were harvested 24 h post-
infection and used as positive and negative controls, respectively. (H) CFSE cell tracking of S0 cells as they transition into S1 and S2 in vitro. Sorted S0
cells were pulsed with CFSE and incubated in Epo for 18 h. The time points examined during in vitro incubation are indicated. Upper panel: CD71/
Ter119 profiles. The S0 (blue), S1 (red), and S2 (green) gates are indicated with the percentage of cells in each gate. Middle panel: Corresponding CFSE
histograms for cells in each of the S0 (blue), S1 (red), and S2 (green) subsets. Lower panel: Median fluorescence intensity of CSFE for the
corresponding histograms and colors shown in the middle panel. Representative of 4 similar experiments. (I) Representation of the transition from S0
to S1. S0 contains several CFU-e generations. The last generation of CFU-e, noted as ‘‘CFU-e.2,’’ arises in S0 as an EpoR-independent cell. The onset of
EpoR dependence and upregulation of CD71 ( = transition to S1) occur during S-phase of this cell generation. Upregulation of Ter119 ( = transition
into S2) occurs as the CFU-e.2 cell divides, giving rise to non-CFU-e progeny in S2. Other than the cell cycle corresponding to CFU-e.2, the timing of
other cell cycles with respect to differentiation events is not known. See also Figure S1.
doi:10.1371/journal.pbio.1000484.g001
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finding that fetal liver cells expressing non-erythroid lineage
markers, which were limited to S0, formed up to 30% of this
subset (Figure 1D, Figure S1B). Non-erythroid colony-forming
progenitors were also restricted to S0, where they formed less than
5% of all colony-forming cells (Figure 1C). Our conclusion that
65%–70% of S0 cells are CFU-e was further supported by single
cell RT-PCR, which showed that 68% of S0 cells expressed EpoR
mRNA (Figure S1C).
In all the experiments that follow, ‘‘S0’’ refers to S0 cells from
which cells expressing non-erythroid markers were excluded by
flow-cytometric gating or sorting.
S1 Cells Are Synchronized in S-Phase of a Single Cell
Cycle
To examine the cell cycle status of erythroid subsets S0 to S5 in
vivo, we injected pregnant female mice with the nucleotide
analogue bromodeoxyuridine (BrdU) and harvested fetal livers
30 min post-injection. We sorted cells from each of S0 to S5 and
stained them with antibodies directed at BrdU (Figure 1E,F). Cells
that incorporated BrdU were in S-phase of the cell cycle at the time
of harvesting. Subsets S4 to S5 showed a rapid decline in the
number of S-phase cells, consistent with cell cycle exit of terminally
differentiating cells. Unexpectedly, we noted that <90% of S1 cells
were in S phase, as compared with <50% of cells in S0
(Figure 1E,F). In addition, the intensity of the BrdU fluorescence
within S1 cells was approximately 50% higher than in S0,
suggesting a higher rate of DNA synthesis (Figure S1D). Similar
experiments with EpoR2/2 fetal liver showed that EpoR appears to
have no effect on progenitor cell cycle status (Figure S1E).
Consistent with the higher number of S-phase cells in S1, we
found a corresponding increase in the E cyclins in S1 compared
with S0 (Figure 1G). Strikingly, we noted .30-fold decrease in the
CDKI p57KIP2 mRNA, but no significant change in the mRNA of
other members of the CIP/KIP CDKI family; there was induction
in p27KIP1 later in differentiation, in subsets S2 and S3 (Figure 1G
and Figure S1F) [22,23]. The p57KIP2 protein also decreased at
the S0 to S1 transition (Figure 1G lower panel).
The finding that nearly all S1 cells were in S-phase could be due
to an unusual cell division cycle with short or no gap phases.
Alternatively, S1 cells may be synchronized in S-phase of the cycle.
The latter explanation would require that cells spend only a brief
period of a few hours in S1, lasting through part or all of a single S
phase. The preceding G1 phase of this same cell cycle would have
occurred prior to the transition from S0 to S1. The G2 and M
phases of this same cycle would occur as cells upregulate Ter119
and transition into S2.
To investigate these possibilities, we isolated S0 cells by flow-
cytometry, labeled them with the cell-tracking dye carboxyfluor-
escein diacetate succinimidyl ester (CFSE), and followed their Epo-
dependent differentiation into S1 in vitro (Figure 1H). By 10 h,
53% of S0 cells transitioned into S1 in the absence of cell division,
as indicated by a single CFSE peak for S1 (solid red histogram,
t = 10 h) that was identical in intensity to that of the CFSE peak
for S0 (blue histogram, t = 10 h; median CFSE fluorescence for
both S1 and S0 peaks = 4,400). This suggested that the transition
from S0 to S1 occurred in the absence of cell division, within a
single cell cycle. Four hours later, at t = 14 h, essentially all S1 cells
had divided once, as indicated by the halving of the CFSE signal
(red histogram at t = 14 h, CFSE fluorescence = 2,100). The
simultaneous division of S1 cells suggested they were synchronized
in their cell cycle phase. By contrast, only a portion of S0 cells,
which were presumably asynchronous in their cell cycle phase, had
divided at this time, resulting in a biphasic CFSE peak (blue
histogram, t = 14 h).
Taken together, these results suggest that the most mature
CFU-e progenitor (‘‘CFU-e.2’’, Figure 1I), capable of giving rise to
an eight-cell colony, traverses S0, S1, and enters S2 within a single
cell cycle. This progenitor arises in S0, becomes Epo dependent,
and upregulates CD71, transitioning into S1 during S-phase of its
cell cycle. Upregulation of Ter119 occurs at approximately the
same time that it completes its cycle and divides, giving rise to
progeny that lack CFU-e activity in S2 (Figure 1C). These
conclusions are consistent with essentially all S1 cells being in S-
phase (Figure 1E,F), and with our finding that nearly all S1 cells
are sensitive to hydroxyurea, a drug that specifically targets S-
phase cells (Figure S2A). These conclusions are consistent with a
number of other observations: the loss of CFU-e activity with
Ter119 expression (Figure 1C, [24]), the short time span (,15 h)
that freshly sorted S0 cells require to transition through S1 and
into S2 (compare with an estimated cell cycle length of 16 h for a
CFU-e cell that will undergo three cell divisions in 48 h, giving rise
to an eight cell colony), and with early work suggesting that Epo
dependence first occurs in early S-phase of a specific CFU-e cell
generation [25]. These conclusions are also consistent with the
finding that EpoR2/2 embryos have normal numbers of CFU-e
[6]: though EpoR2/2 embryos lack S1 cells, all the CFU-e in S1
first arise as Epo-independent cells in S0, where they are
presumably retained in the EpoR2/2 fetal liver.
S-Phase Progression Is Required for the Transition from
S0 to S1
There are two ways to explain how upregulation of CD71, a
differentiation event, might coincide with S-phase, a cell cycle
event. These events may have each been initiated in parallel by a
common upstream regulator, such as the EpoR, since both occur
at the time that cells become EpoR dependent. Alternatively, there
may be a direct mechanistic link between the differentiation and
cell cycle programs. To distinguish these possibilities, we examined
whether a block to S-phase progression would interfere with CD71
upregulation (Figure 2). We incubated sorted S0 cells in vitro for
10 h in the presence of Epo, and either in the presence or absence
of aphidicolin, an inhibitor of DNA polymerase that arrests S-
phase progression [26]. At t = 10 h, cells were washed free of
aphidicolin and incubated in Epo alone for an additional 10 h
(Figure 2A). In the initial 10 h of incubation, there was an Epo-
dependent transition of cells from S0 to S1 (Figure 2C, rows 1 and
5). However, the presence of aphidicolin blocked this transition
(Figure 2C, rows 2 & 3, t = 10 h). Both S-phase and the transition
into S1 resumed once the cells were washed free of aphidicolin
(Figure 2C, rows 2 & 3, t = 20 h). These observations suggested
that the transition from S0 to S1 occurred during S-phase and
required both Epo and S-phase progression.
We also examined the effect of mimosine, a plant amino acid
that blocks cell cycle progression in late G1 [27]. We incubated
sorted S0 cells in Epo and in the presence or absence of mimosine.
By 4 h of incubation, the majority of cells were arrested in G1.
However, a small fraction of cells (12%) could be seen in S-phase
at t = 4 h (Figure 2C, row 4, BrdU/7AAD at t = 4 h). Presumably,
at the time mimosine was added, these cells were advanced in their
cell cycle beyond the point at which mimosine exerts its block.
BrdU/7AAD analysis showed that these cells were in the early half
of S-phase and expressed the highest CD71 levels within the S0
subset (Figure 2D, cells marked in red). By t = 10 h, no S-phase
cells were seen in S0, presumably because they have now
transitioned into S1, where a similar number of cells (15%) had
newly appeared (Figure 2C, row 4, BrdU/7AAD for S0 at
t = 10 h, and CD71/Ter119 for S1 at t = 10 h). These observa-
tions were consistent with the onset of CD71 upregulation
S-Phase Coordinates Erythroid Commitment
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Figure 2. The S0 to S1 transition requires S-phase progression. (A) Design of experiments illustrated in sections (B–D). Flow-cytometrically
sorted S0 cells were incubated in Epo for 20 h. In the first 10 h, cells were also in the presence or absence of a cell cycle blocking drug, either
aphidicolin (Aphi) or mimosine (Mim). DMSO was added to control cells in the Aphi experiments. Aphi or Mim were removed by washing at t = 10 h.
S-Phase Coordinates Erythroid Commitment
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occurring in early S-phase in S0, culminating in the transition to
S1 later within that same S-phase.
CD71, the transferrin receptor, is required during erythroid
differentiation in order to facilitate cellular uptake of iron for
hemoglobin synthesis. CD71 is also expressed, albeit at lower
levels, on all cycling cells. We therefore examined whether, in the
context of S1 cells, CD71 might be required specifically for S-
phase progression. We used RNAi to prevent CD71 upregulation
in S0 cells during their incubation in Epo (Figure S2B,C). The
failure of these cells to upregulate CD71 did not interfere with the
number of cells in S-phase (Figure S2B). Therefore, the link
between S-phase progression and CD71 upregulation in S1 cells is
not due to a cell cycle function for this gene.
The S0 to S1 Transition Is Marked by Downregulation of
PU.1 and GATA-2 and Precedes Induction of Erythroid-
Specific Genes
To investigate the link between S-phase and the erythroid
differentiation program, we examined expression of erythroid
transcriptional regulators and erythroid-specific genes in freshly
sorted fetal liver subsets and in fetal brain (Figure 3A). We found
that the GATA-1 mRNA was present in S0 cells, at 200-fold
higher levels than in fetal brain (Figure 3A) and 40-fold higher
level than in Mac-1+ cells (Figure S3A). It increased a further <2-
fold with the transition from S0 into S1 and continued to increase
in S2 and S3. Of note, total RNA per cell decreased 4-fold over
the course of differentiation from S2 to S4 (Figure S3B), suggesting
an overall modest increase in GATA-1 mRNA per cell over this
period. Other erythroid transcriptional activators and GATA-1
associated factors, including EKLF, NF-E2 [28], SCL/Tal-1, and
Lmo2, showed a similar expression pattern to that of GATA-1
(Figure 3A). Therefore, expression of GATA-1 and of other
activators of the erythroid transcriptional program precedes the
transition from S0 to S1. By contrast, we found that PU.1, a
repressor of GATA-1 function, and GATA-2, a target of GATA-1-
mediated repression [29], were both downregulated <30-fold and
<20-fold, respectively, at the S0 to S1 transition, becoming
undetectable with further differentiation (Figure 3A). Prior to its
downregulation, the level of PU.1 in S0 cells was comparable to
that of myeloid Mac-1+ cells (Figure S3A). PU.1 protein levels also
declined with the transition from S0 to S1 (Figure S3C).
EpoR2/2 fetal liver cells, though apparently arrested at the S0
stage (Figure 1B), have a similar expression pattern of transcrip-
tional regulators to wild-type S1 (Figure 3A). Therefore,
downregulation of PU.1 and GATA-2 at the S0 to S1 transition,
as well as the preceding induction of GATA-1, are independent of
EpoR signaling.
We examined expression of several erythroid-specific GATA-1
target genes: b-globin (Hbb-b1); the first enzyme of heme synthesis,
aminolevulinic acid synthase 2 (ALAS2); and the anion exchanger
Band 3 (Slc4a1), a major erythrocyte membrane protein [30].
There was a modest increase in their expression at the S0 to S1
transition, followed by a 30–100-fold induction during subsequent
differentiation in S2 and S3 (Figure 3A). Expression of the EpoR
gene, itself a GATA-1 target, increased 10-fold above its S0 level
with the transition to S1 (Figure S3D). Taken together, induction
of erythroid GATA-1 target genes and repression of GATA-2
suggest that GATA-1 function is activated at the S0 to S1
transition. The modest increase in GATA-1 mRNA at this time
suggests that its activation may be principally a result of PU.1
downregulation.
S-Phase Arrest at the S0 to S1 Transition Blocks Induction
of Erythroid-Specific Genes
We had found that S-phase progression at the transition from
S0 to S1 was required for CD71 upregulation (Figure 2). We
therefore examined whether S-phase progression at this time was
also required for induction of erythroid-specific genes. We cultured
sorted S0 cells in Epo for 10 h, a period sufficient for 25%–50% of
cells to transition into S1 (Figures 1H, 2C), and examined the
effect of adding aphidicolin to the culture. Cells were then washed
free of aphidicolin, continuing incubation in Epo alone. Cells
incubated in Epo alone for the entire period showed <50- to 100-
fold induction in the mRNAs for b-globin, Band 3, and ALAS2
(Figure 3B, red curves). By contrast, cells that were subject to
aphidicolin treatment during the initial 10 h showed reduced
mRNA induction by the end of the culture period (Figure 3B, blue
curves). The reduced mRNA levels corresponded closely to the
levels predicted had there been a 10 h delay in the time course of
induction for each of the genes (Figure 3B, black curves).
Therefore, induction of erythroid-specific genes was likely blocked
during the incubation period in aphidicolin.
We also examined whether S-phase arrest interferes with
erythroid gene induction if applied at the S1 stage of differenti-
ation. We sorted S1 cells and incubated them in Epo, either in the
presence or absence of aphidicolin. Unlike S0 cells, aphidicolin-
mediated S-phase arrest of S1 did not interfere substantially with
their induction of erythroid specific genes, as shown by the
unperturbed induction of b-globin, Alas2, and Band 3 (Figure 3C,
Figure S3E) or with the upregulation of Ter119 (Figure S3F).
Therefore, S-phase progression is required for activation of
erythroid-specific genes, specifically at the S0 to S1 transition,
but not a few hours later when the cells have traversed into S1.
The lack of effect of aphidicolin on mRNA induction in S1
suggests its effects in S0 are not due to non-specific suppression of
transcription.
S-Phase Arrest at the S0 to S1 Transition Blocks
Downregulation of PU.1 and GATA-2 and Arrests
Erythroid Morphological Maturation
Transcripts for PU.1 and GATA-2 are markedly downregulated
at the transition from S0 to S1 (Figure 3A). We examined whether
S-phase arrest interferes with their downregulation. Sorted S0 cells
were incubated in Epo for 4 h, at which time, just prior to their
transition into S1 (Figure 2C), aphidicolin was added to the
cultures for a period of 10 h. Cells were then washed free of
aphidicolin and incubated in Epo for a further 10 h. Aphidicolin
halted the downregulation of both PU.1 and GATA-2, which
Cell cycle status and CD71/Ter119 expression were examined at 4, 10, and 20 h. (B) CD71/Ter119 expression and BrdU/7AAD cell cycle profile of
freshly sorted S0 cells at t = 0. Cells were incubated in the presence of BrdU for 30 min prior to fixation, permeabilization, and staining with antibodies
for CD71, Ter119, and BrdU. (C) CD71/Ter119 expression (left columns) and corresponding cell cycle profile of S0 and S1 cells (right columns) at the
indicated time points. The presence or absence of Epo, Aphi, or Mim is indicated above each row of histograms. The indicated percentages
correspond to the fraction of cells in S1 (left columns) or in S-phase of the cycle (right columns). Note that Ter119 signal is reduced in fixed and
permeabilized cells compared with equivalent non-fixed cells (e.g., Figure 1H and Figure S2A), since the Ter119 epitope is partially detergent soluble.
Data representative of five experiments. (D) ‘‘Back-gating’’ analysis for CD71 expression of S0 cells that are either in G1 (blue) or in S-phase (red), at
t = 4 h in the presence of Epo+Mim. The same BrdU/7AAD profile as in section (C), row 4, t = 4 h. See also Figure S2.
doi:10.1371/journal.pbio.1000484.g002
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Figure 3. Block of S-phase progression at the S0 to S1 transition arrests the erythroid differentiation program. (A) Expression of
transcriptional regulators (upper panel) and erythroid-specific genes (lower panel) in sorted fetal liver subsets S0 to S3, in fetal brain, and in lineage
marker-depleted EpoR2/2 fetal liver. mRNA measured by quantitative RT-PCR, normalized to the b-actin mRNA, and expressed as a ratio to the S0
subset. Data are mean 6 SD of 2 (for EpoR2/2 and brain) or 3 (for S0 to S3) independent experiments. (B, C) Effect of aphidicolin-mediated S-phase
arrest on erythroid-specific gene expression. Sorted S0 (in B) or S1 (in C) cells were incubated in Epo, and in either aphidicolin (3 mM) or DMSO, for the
first 10 h. Aphidicolin and DMSO were removed by washing at t = 10 h. mRNA was measured by qRT-PCR, normalized to b-actin, and expressed as a
ratio to mRNA at t = 10 h in Epo+DMSO. Duplicate independent experiments shown, fitted with exponential curves. Black curves are the calculated
time course for a 10 h delay in induction for each gene, obtained by shifting the respective red curves (describing time course for Epo + DMSO) by
10 h. (D) Effect of aphidicolin-mediated S-phase arrest on PU.1 and GATA-2. Experiment and mRNA measurement as described for (B), except that
aphidicolin and/or DMSO were applied at t = 4 h and removed at t = 14 h. Data from two independent experiments. (E) mRNA expression of
transcriptional regulators GATA-1, GATA-2, and PU.1 at the end of a 10 h incubation in Epo + aphidicolin, compared with cells incubated in Epo +
DMSO. Experimental design and mRNA measurement as described in section (D), with data pooled from nine independent experiments (each with a
distinct symbol). Bar indicates position of mean. Differences between Epo+ aphidicolin and Epo control samples are significant (paired two-tailed t
test) for GATA-2 (p=0.004) and for PU.1 (p= 0.002). (F) Effect of aphidicolin or mimosine-mediated S-phase arrest on erythroblast morphology during
differentiation of S0 cells in vitro. Sorted S0 were incubated in Epo, and for the first 10 h of incubation, also in the presence of either aphidicolin or
mimosine. Control cells were incubated in Epo alone throughout. Cytospin preparations of cells at 10 and 20 h of incubation are shown, stained with
Giemsa. Morphological maturation (decreasing cell and nuclear size), compared with control cells, was arrested at t = 10 h, and remained delayed
when the block to cell cycle progression was removed (t = 20 h). (G) S-phase arrest by overexpression of a non-degradable mutant of p57KIP2
(p57T329A). Sorted S0 cells were transduced with retroviral vector expressing p57T329A linked to IRES-hCD4 reporter, or with control vector (MICD4).
Cells were cultured for 15 h in IL-3 and SCF and transferred to an Epo containing medium at t = 0, to allow their transition from S0 to S1. CD71/Ter119
profiles of infected, hCD4 positive S0 at t = 0 and t = 14 h (upper panels) and BrdU/7AAD cell cycle profiles (lower panels) at t = 14 h are shown.
Representative of 4 experiments. Transduction efficiency of p57KIP2 exceeded 90% in all experiments. (H) Transcriptional regulators GATA-1, GATA-2,
and PU.1 in cells expressing p57T329A. Experiment as described in (G). mRNAs measured by qRT-PCR following 24 h of incubation in Epo, and
expressed relative to cells transduced with control vector (MICD4) after normalization to b-actin. Duplicate independent experiments are shown. (I)
Representation of erythroid gene expression at the transition from S0 to S1. GATA-1 and other activators of the erythroid transcriptional program are
induced at an unknown time preceding the S0/S1 boundary, and increase modestly with further differentiation. P57KIP2, PU.1, and GATA-2 are
expressed in S0 and are markedly downregulated at the S0 to S1 transition. Erythroid specific Ter119, b-globin, ALAS2, and Band3 are induced
subsequent to the S0/S1 boundary. S-phase arrest at this stage (dashed black line) results in arrest of all subsequent events, including PU.1 and GATA-
2 downregulation, CD71 and Ter119 expression, erythroid-specific gene induction, and morphological maturation. See also Figure S3.
doi:10.1371/journal.pbio.1000484.g003
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resumed once the cells were washed free of the drug (Figure 3D,E).
Similar results were obtained in cells treated with mimosine
(Figure S3G). Therefore, S-phase progression is required for
downregulation of PU.1 and GATA-2 at the S0 to S1 transition.
Of note, GATA-1, Nfe2, and Lmo2 mRNAs, which did not
change significantly during the transition from S0 to S1
(Figure 3A), were not altered significantly by the aphidicolin
treatment (Figure 3E, Figure S3H).
We also examined the effects of aphidicolin or mimosine
treatment on morphological maturation of S0 cells cultured in
Epo. Following 10 h in Epo in the presence of aphidicolin or
mimosine, cells appeared larger than cells incubated in Epo alone.
This suggested that, while S-phase progression and the erythroid
differentiation program had both arrested, cell growth was not
perturbed (Figure 3F). Cells were then washed free of aphidicolin
or mimosine and cultured in Epo alone. By 20 h, erythroid
maturation had resumed in cells that were initially incubated in
cell cycle blocking drugs, as judged by decreasing cell size, nuclear
condensation, and decreased nuclear to cytoplasmic ratio, but was
nevertheless delayed when compared with control cells. These
results are consistent with the effect of S-phase arrest on gene
expression (Figure 3B,D,E) and suggest that S-phase progression at
the S0 to S1 transition is a key requirement for activation of the
erythroid differentiation program.
Preventing p57KIP2 Downregulation Blocks S-Phase
Progression at the S0 to S1 Transition and Arrests
Erythroid Differentiation
Expression of p57KIP2 mRNA decreases over 30-fold at the S0 to
S1 transition, and this is associated with downregulation of the
p57KIP2 protein (Figure 1G). To examine the effect of preventing
p57KIP2 downregulation, we generated a point mutant of p57KIP2,
p57T329A, analogous to a proteolysis-resistant human p57KIP2
mutant [31]. Sorted S0 cells were infected with bicistronic retroviral
vectors expressing either wild-type p57KIP2 or p57T329A, linked
through an internal ribosomal entry site (IRES) to a human CD4
(hCD4) reporter; control cells were infected with retroviral vector
expressing the IRES-hCD4 construct only (MICD4). To allow
expression of the transduced p57KIP2, infected cells were cultured
for 15 h in stem-cell factor (SCF) and interleukin 3 (IL-3), cytokines
that sustain viability of progenitors but, unlike Epo, do not support
differentiation from S0 to S1. Infected S0 cells were then transferred
to Epo for 14 h (Figure 3G). Expression of either wild-type
(unpublished data) or mutant p57KIP2, but not expression of
MICD4, resulted in a block to S-phase progression and inhibited
the transition from S0 to S1 (Figure 3G). Further, PU.1 mRNA was
.3-fold higher in cells expressing p57KIP2 compared with control
cells expressing vector only (Figure 3H), suggesting that, as in the
case of aphidicolin-mediated S-phase arrest, p57KIP2-mediated S-
phase arrest prevents downregulation of PU.1 at the transition from
S0 to S1. Erythroid morphological maturation, but not cell growth,
of p57T329A-transduced cells was also arrested (Figure S3I).
Taken together, upregulation of CD71, which defines the
transition from S0 to S1, identifies a key differentiation transition
within the last generation of CFU-e (‘‘CFU-e.2’’, Figure 3I). It
marks the onset of EpoR dependence and occurs exclusively during
S-phase of the cell cycle. Induction of GATA-1 and other activators
of the erythroid transcriptional program precedes this transition,
whereas induction of erythroid-specific genes such as b-globin and
Ter119 follows it. The S0 to S1 transition coincides with rapid
downregulation of p57KIP2, PU.1, and GATA-2. Both Epo and S-
phase progression are required for upregulation of CD71. S-phase
progression at the S0 to S1 transition requires the downregulation of
p57KIP2 and is in turn required for the downregulation of PU.1 and
GATA-2 and the subsequent activation of erythroid-specific genes.
By contrast, S-phase arrest in S1 cells does not affect erythroid gene
activation (Figures 3C, S3E–F).
Persistently Elevated PU.1 Arrests S-Phase Progression
and Blocks Erythroid Differentiation
Both PU.1 and GATA-2 were rapidly and dramatically
downregulated at the transition from S0 to S1 (Figure 3A, Figure
S3A). We examined the effect of preventing this downregulation by
expressing either PU.1 (Figure 4A–D) or GATA-2 (Figures 4E,
S4C,D) in S0 cells using retroviral constructs and a similar strategy
to that described above for p57KIP2. Following infection, S0 cells
were cultured for 15 h in IL-3 and SCF and then transferred to Epo
for 24 h, when CD71/Ter119 and cell cycle profiles were examined
(Figure 4A–C). We divided the PU.1 expression profile at t = 24 h
into 7 sequential hCD4 gates labeled (i) to (vii) (Figure 4A), each
containing cells with increasing levels of the hCD4 reporter and,
therefore, increasing levels of PU.1. By measuring PU.1 protein
directly in fixed and permeabilized cells using a PU.1-specific
antibody and flow-cytometry, we found that hCD4 protein
expression was a reliable reporter of exogenous PU.1 protein
expression in our system (Figures 4D, S4A–B); expression of
transduced PU.1 was also measured by qPCR (Figure S4D).
Sequential hCD4 gates were also obtained for control cells
expressing the empty MICD4 vector. PU.1 expression blocked
transition from S0 to S1, with the number of cells transitioning into
S1 declining as PU.1 expression increased (Figure 4B, upper panels).
PU.1 expression also resulted in a decrease in the number of S-
phase cells, with cells arresting principally at the transition from G1
to S-phase, though there was also an increase in the number of cells
within G2 or M (Figure 4B, lower panels). The decrease in the
number of cells in S1 was paralleled by decreased S-phase cell
number, suggesting a direct correlation between the PU.1-mediated
block of the transition from S0 to S1, and its inhibitory effect on S-
phase (Figure 4C). Therefore, PU.1 inhibits both S-phase and
erythroid differentiation at the S0 to S1 transition.
Since the downregulation of both PU.1 and p57KIP2 are
required for S-phase progression and for the transition from S0 to
S1 (Figure 3G, Figure 4B,C), we examined whether PU.1 may be
a regulator of p57KIP2. However, we found that exogenous
expression of PU.1 did not prevent downregulation of p57KIP2
(Figure S4E). Therefore, PU.1’s inhibitory effect on S-phase is not
mediated via p57KIP2.
In contrast to PU.1, expression of GATA-2 in S0 cells did not
prevent transition into S1, though it somewhat reduced the
subsequent transition from S1 to S2 (Figure 4E). GATA-1
overexpression in S0 cells had the opposite effect, of promoting
the transition from S1 to S2. There was no significant effect of
either GATA-1 or GATA-2 on the cell cycle profile (Figure 4E).
The S0 to S1 Transition Coincides with a Switch in the
Timing of Replication of the b-Globin Locus
A long-standing hypothesis suggests that DNA replication may
provide an opportunity for the restructuring of chromatin at tissue-
specific gene loci [4,5]. Given the requirement for DNA
replication for the transition from S0 to S1, we asked whether
chromatin change may be taking place at this time. The b-globin
gene locus (Figure 5A) is a well-studied model of tissue-specific
gene expression. The features that characterize the open
chromatin conformation at the actively transcribed locus in
erythroid cells have been established, but the time during
development when the active chromatin conformation is acquired
is not known. We therefore set out to examine whether the S0 to
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Figure 4. PU.1, but not GATA-2, inhibits the transition from S0 to S1. (A–C) Effect of exogenous PU.1 on the transition from S0 to S1. Sorted
S0 cells were transduced with retroviral vector expressing PU.1-IRES-hCD4 (PU.1-ICD4) or control vector (MICD4) and were incubated in IL-3 and SCF
for 15 h before being transferred to Epo for 24 h. (A) Expression profiles of the hCD4 reporter in cells transduced with either PU.1-ICD4 or with control
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S1 transition might coincide with an alteration in the structure or
function of chromatin at this locus.
The timing of replication of the b-globin locus is correlated with
its chromatin state. In higher eukaryotes the timing of replication
of genes correlates with their transcriptional activity [32].
Housekeeping genes replicate early in S-phase, whereas silent
chromatin and heterochromatin replicate late. The b-globin locus
replicates in mid to late S-phase in non-erythroid cells, and early in
S-phase in erythroid cells [33]. We examined the timing of
replication of the b-globin locus in S0 and S1 cells sorted from
fresh fetal liver. Individual alleles were identified using fluores-
cence in situ hybridization (FISH) with a probe directed at the b-
major gene. Cells in S-phase were identified by positive staining
for BrdU incorporation. Nuclei from at least 100 S-phase cells
from either S0 or S1 were examined in each of two experiments
(Figure 5B). Using this approach, two single dots (‘‘SS’’) suggest
that neither of the b-globin alleles had yet replicated. Nuclei in
which both alleles have replicated contain a pattern of two double
dots (‘‘DD’’). Replication of only one allele results in one single
and one double dot (SD) [33]. We found that the number of cells
with a DD pattern increased from only 15% in S0 to over 50% in
S1 (Figure 5B), suggesting a switch in the timing of replication
from late to early S-phase. In addition, an average of 36% of S0
cells, but only 21% of S1, had an SD pattern, consistent with a
switch from late, asynchronous replication in S0 to early,
synchronous replication in S1 [33].
The S0 to S1 Transition Coincides with the Onset of
DNase I Hypersensitivity at the b-Globin Locus Control
Region (LCR)
A key indicator of open chromatin at the b-globin LCR is the
presence of hypersensitivity (HS) sites (Figure 5A). We prepared
nuclei from freshly sorted S0 or S1 cells and tested their sensitivity to
DNase I digestion. Following digestion, we measured remaining
DNA using quantitative PCR, with amplicons within HS2, HS3, and
HS4 [34]. Results were expressed as a ratio to the DNase I resistant,
non-expressing neural gene, Nfm. We found that S0 cells were
relatively resistant to DNase I, while S1 cells were hypersensitive at
all tested HS sites (Figure 5C). Therefore, the S0 to S1 transition
coincides with the onset of DNase I hypersensitivity at the b-globin
LCR.
We also examined E12.5 EpoR2/2 whole fetal livers, which do
not contain S1 cells (Figure 1B). We found that EpoR2/2 fetal
livers were resistant to DNase I, whereas whole fetal livers from
wild-type or heterozygous littermates showed the expected
hypersensitive sites (Figure 5D). We therefore concluded that
DNase I hypersensitivity develops at the S0 to S1 transition,
synchronously with the onset of EpoR dependence.
S-Phase Progression Is Required for the Onset of DNase I
Hypersensitivity at the b-Globin LCR
Since the transition from S0 to S1 coincides with, and requires,
S-phase progression, we examined whether development of DNase
I hypersensitivity at the b-globin LCR also requires S-phase
progression. We incubated sorted S0 cells in Epo, in the presence
or absence of aphidicolin, for 10 h. Over this period 25%–50% of
S0 cells transition into S1, a process arrested by aphidicolin
(Figures 1H, 2C). At the end of a 10-h incubation period, nuclei
were prepared and digested with varying concentrations of DNase
I. There was a clear increase in DNase I sensitivity in cells
incubated in Epo alone, relative to cells incubated in Epo and
aphidicolin (Figure 5E). Therefore, the development of DNase I
hypersensitivity at the S0 to S1 transition is dependent on S-phase
progression.
Changes in Post-Translational Histone Tail Modifications
Associated with the Transition from S0 to S1
The switch in timing of replication and in DNase I
hypersensitivity at the S0 to S1 boundary suggested the b-globin
LCR was undergoing structural changes. To investigate these, we
used chromatin immunoprecipitation (ChIP) to determine
specific histone tail modifications at the b-globin LCR in freshly
sorted S0, S1, and in fetal brain. We used ChIP-qPCR for
amplicons at the b-globin LCR HS sites, or at a control, neural
gene, Nfm. Changes in histone modifications were expressed as a
ratio, between S0 and either S1 or fetal brain (Figure 5F,G).
Figure 5F summarizes data pooled from seven experiments with
various immunoprecipitating antibodies as indicated. A compar-
ison of S1 with S0 shows a 7-fold decrease in trimethylation of
histone 3 lysine 27 (H3K27me3, p=0.019, paired t test), a mark
associated with silent chromatin, and a 2.5-fold increase in
histone 3 lysine 4 dimethylation, a mark associated with active
chromatin (H3K4me2, p= 0.032), at the HS2 site of the b-globin
LCR. A similar trend for these two modifications was also found
at other HS sites (p=0.0006 and p=0.011 for H3K4me2 and
H3K27me3, respectively, pooling all HS sites). An increase in
acetyl marks in histones H3 and H4 associated with active
chromatin was also seen consistently across the HS sites tested,
though it did not reach statistical significance. Of note, no
significant changes in histone marks were found between S0 and
S1 at the Nfm gene. Further, there was no significant change in
total histone occupancy of the HS sites between S0 and S1, as
determined by ChIP with antibodies directed against total H3
and H4 (Figure 5F).
We noted that H3K27me3, associated with silent chromatin,
and H3K4me2, associated with active chromatin, were both
enriched in S0 compared with fetal brain (Figure 5G, lower panel).
These results were suggestive of bivalent chromatin at the b-globin
LCR in S0, and loss of the repressive H3K27me3 mark with
transition into S1 (Figure 5G, upper panel, 5F).
The Transition from S0 to S1 Coincides with S-Phase-
Dependent DNA Demethylation at the b-Globin LCR
We examined DNA methylation of six CpG dinucleotides, three
each at the HS1 and HS2 sites of the b-globin LCR (Figures 5A,
6A). Genomic DNA was prepared from sorted hematopoietic cell
MICD4, at 24 h of Epo culture. Vertical, narrow gates each containing cells of relatively uniform hCD4 expression are shown and numbered (i to vii)
and are used in the analysis shown in sections (B) and (C) below. (B) CD71/Ter119 (upper panels) and cell cycle (lower panels) analysis of cells in
individual hCD4 gates (ii) to (v), at t = 24 h. Higher hCD4 indicates higher PU.1 expression in cells transduced with PU.1-ICD4. (C) Summary of
histogram data in (B), correlating cell cycle and differentiation data to hCD4 expression. Each data point corresponds to one of the hCD4 vertical
gates marked in (A). Data are representative of five independent experiments. (D) Linear correlation between PU.1 expression levels as measured by
flow-cytometry using a PU.1-specific antibody, and hCD4 levels, in cells transduced either with PU.1-ICD4 or with control MICD4. Summary of data
shown in Figure S4A,B. Data are representative of 2 independent experiments. (E) Effect of exogenous GATA-1 or GATA-2 on S0 cell differentiation
and cell cycle. Experimental design as in section (A–C). CD71/Ter119 and cell cycle profiles are shown for hCD4+ cells transduced with the indicated
retrovirus. Flow-cytomeric expression of retroviral constructs is shown in Figure S4C.
doi:10.1371/journal.pbio.1000484.g004
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subsets from fresh fetal liver, including S0, S1, megakaryocytic
CD41+, myeloid Mac-1+, and Lin2Sca1+Kit+ (LSK) cells,
enriched for hematopoietic stem-cells. We also examined
EpoR2/2 fetal livers depleted of cells expressing lineage markers,
and fetal brain. DNA methylation at each of the six CpGs was
obtained following bisufite conversion of genomic DNA, PCR
Figure 5. The S0 to S1 transition coincides with an S-phase dependent switch in the state of chromatin at the b-globin locus. (A) A map
of the mouse b-globin locus. b-globin genes are indicated with horizontal arrowheads. Vertical arrows indicate DNase I hypersensitivity sites (HSs). Solid
arrows for HS1 to HS4 indicate sites examined in experiments below. Expanded HS1 and HS2 sites show locations of CpG dinucleotides (labeled HS1A, B,
C, and HS2A, B, C). (B) FISH analysis of the timing of replication at the b-globin locus. Pregnant female mice were injected with BrdU 30 min prior to
harvesting of fetal livers. Sorted S0 and S1 cells were fixed and stained for BrdU (red) to identify S-phase cells. Cells were hybridized with a probe to the b-
major gene (green), and the number of hybridization spots in 100 BrdU-positive cells in consecutive fields for each of S0 or S1 were counted by
fluorescence microscopy, in two independent experiments. Cells were scored as DD (two double dots, indicating both alleles have replicated), SD (one
single and one double dot, indicating only one allele has replicated), or SS (two single dots, indicating neither allele has replicated). Examples of nuclei
with each of the patterns are shown. (C) DNase I sensitivity in S0 or S1 cells. Nuclei were prepared from sorted S0 and S1 cells and digested with
increasing concentrations of DNase I for 10 min. DNAwas extracted and quantitative PCR used to measure remaining DNA at each of HS2, HS3, and HS4
using 150 bp amplicons. DNA measurements were normalized to DNA amplified at the neuronal gene Nfm. Representative of three independent
experiments. (D) DNase I sensitivity of whole fetal liver from E12.5 EpoR2/2 and littermate wild-type controls. Method as in (C). Representative of three
independent experiments. (E) Effect of S-phase arrest on development of DNase I hypersensitivity. Sorted S0 cells were incubated in Epo for 10 h to allow
transition to S1, in the presence of aphidicolin (Aphi) or DMSO (control). Nuclei were prepared and DNase I sensitivity measured as described in (C). DNA
in each sample was normalized to Nfm and expressed as a ratio of DNA in cells incubated in Epo + aphidicolin to DNA in cells incubated in Epo + DMSO.
Individual data points are pooled from 3 independent sorting and digestion experiments; curves are fitted second order polynomials. (F,G) ChIP-qPCR in
sorted S0 and S1 cells and in fetal brain. ChIP was performed with the indicated antibodies and with control, isotype-matched antibody. qPCR was of
150 bp amplicons at the LCR HSs and at the b-actin and Nfm genes. Data are expressed as enrichment over input DNA in S1 relative to S0 (in F and in G,
upper panel) or S0 relative to fetal brain (in G, lower panel). Each sample was normalized to b-actin after subtraction of background (ChIP background
was the signal with isotype control antibodies, which was ,10% of the signal obtained with specific antibodies). (F) Summary of seven independent
ChIP-qPCR experiments. Data are means of at least 2 to 4 experiments for each antibody/amplicon combination (SE is provided when at least 3
experiments are averaged for a given antibody/amplicon). * indicates statistically significant difference between S0 and S1 at the HS2 site (p=0.019 and
0.032 for H3K27me3 and H3K4me2, respectively). Changes in H3K27me3 and H3K4me2 over all HSs tested were significant at p=0.011 and p=0.0006,
respectively (paired t test used for all significance tests). (G) Representative ChIP-qPCR experiment that included sorted S0, S1, and fetal brain. Data are
mean 6 SE of three replicates, expressed as a ratio of S1 to S0 (upper panel) and S0 to fetal brain (lower panel).
doi:10.1371/journal.pbio.1000484.g005
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amplification at HS1 and HS2, and pyrosequencing. In fetal brain
methylation levels were high, at <60%–80%, for all six CpG
dinucleotides. Methylation levels were lower in all hematopoietic
cell subsets (Figure 6A). Methylation levels were largely similar in
all hematopoietic, Epo-independent cell subsets examined: LSK,
Mac-1+, CD41+, S0, and EpoR2/2 cells. The onset of Epo
dependence in S1 was associated with a marked reduction in DNA
methylation in all six CpG dinucleotides, with the level of
methylation dropping to virtually undetectable levels in S1 for four
of the six CpGs.
We found that DNA demethylation also took place in freshly
sorted S0 cells allowed to differentiate in vitro (Figure 6B,C).
Demethylation in vitro occurred earlier at the HS1A, B, C, and
HS2C than at HS2A, B (Figure 6C, red lines), in agreement with
results in vivo (Figure 6A). Demethylation in vitro was arrested at
all CpGs if either aphidicolin or mimosine were added to the
incubation medium, and resumed when these drugs were
removed (Figure 6B,C). Therefore, DNA demethylation, initiated
at the transition from S0 to S1, is dependent on S-phase
progression. These results are suggestive of a passive demethyl-
Figure 6. The transition from S0 to S1 is marked by the onset of S-phase dependent, DNA demethylation at HS1 and HS2. (A)
Methylation levels at each of the 6 CpG dinucleotides in HS1 (HS1A, B, C) and HS2 (HS2A, B, C; Figure 5A), in each of the indicated cell populations.
Hematopoietic cells were sorted flow-cytometrically from freshly isolated fetal liver. Brain = fetal brain; LSK = Lin2Sca1+Kit+; Mac-1 =
CD71lowTer1192Mac-1+; CD41= CD71lowTer1192CD41+; EpoR2/2 = Lin2 cells from EpoR2/2 fetal liver. Methylation levels were assessed following
PCR-amplification of bisufite-converted genomic DNA at each of the HS1 and HS2 loci followed by pyrosequencing. Each data point is the mean6 SE
of 2 to 4 independent sorting and pyrosequencing experiments. (B) Arrest of S-phase progression by aphidicolin prevents DNA demethylation.
Aphidicolin was added for 10 h at t = 0 (HS1A, B, C, and HS2C, left panel) or at t = 4 h (HS2A, B, right panel) to sorted S0 cells incubated in Epo for 48
(left panel) or 24 h (right panel). Control cells were incubated in Epo only. CpG methylation was measured at the indicated time points as described in
(A). Data are from two independent experiments. (C) Arrest of S-phase entry by mimosine prevents DNA demethylation. Sorted S0 cells were
incubated in Epo for 24 h, in the presence or absence of mimosine between t = 4 and t = 14 h. CpG methylation was measured as described in (A).
Data are mean 6 SE of three independent sorting and pyrosequencing experiments. (D) Preventing PU.1 downregulation prevents DNA
demethylation of HS1 and HS2 at the S0 to S1 transition. S0 cells were transduced with retroviral vectors expressing either PU.1-ICD4 or MICD4 as
described in Figure 4A–C. CpG methylation levels were measured as described in (A) following 24-h incubation in Epo. Data are mean 6 SE of three
independent experiments (cells were transduced with PU.1-ICD4 at .90% efficiency in one experiment, and in two additional experiments hCD4+
cells were sorted before the start of Epo incubation).
doi:10.1371/journal.pbio.1000484.g006
S-Phase Coordinates Erythroid Commitment
PLoS Biology | www.plosbiology.org 12 September 2010 | Volume 8 | Issue 9 | e1000484
ation process, due to loss of maintenance methylation at nascent
DNA.
PU.1 Downregulation Is Required for the Onset of DNA
Demethylation at the Transition from S0 to S1
We examined HS1 and HS2 DNA methylation levels in S0 cells
transduced with PU.1 (as in Figure 4A) and incubated in Epo for
24 h. DNA methylation was significantly higher at 3 of the 6 CpGs
in S0 cells transduced with PU.1-ICD4, compared with control
cells transduced with MICD4 (Figure 6D). Therefore, PU.1
expression, along with its inhibitory effect on erythroid differen-
tiation, also impaired DNA demethylation, possibly due to its
inhibitory effect on S-phase in these cells (Figure 4C).
Discussion
We have identified a committal step in erythropoiesis in which
the cell cycle clock is precisely synchronized with and coordinates an
erythroid differentiation switch. It takes place during S-phase of the
last CFU-e generation, at the transition from S0 to S1, when S-
phase progression is required for several distinct committal
differentiation events, including the onset of Epo dependence, a
switch in chromatin at the b-globin locus into an open
conformation, and activation of GATA-1 function with consequent
transcription of GATA-1 target genes (Figure 7A). The transition
from S0 to S1 can be replicated in vitro, where sorted S0 cells
develop into a differentiation state characteristic of S1 within 10 to
12 h.
S-phase progression at the S0 to S1 transition and the ensuing
differentiation switch are dependent on the downregulation of
p57KIP2 (Figures 3G, 7B), a novel finding since, to date, the
principal known role of CDKIs in differentiating cells had been to
mediate terminal differentiation secondary to cell cycle exit [1–3].
Unlike other CDKIs, p57KIP2 is required for the development of
multiple tissues [35], suggesting that its novel role in erythropoi-
esis, triggering S-phase progression during a committal differen-
tiation event, may be replicated in other systems. Of note, p57KIP2
is the only CDKI of the CIP/KIP family to be downregulated at
the S0/S1 transition.
The synchronization of S-phase progression with several rapid
and committal differentiation transitions suggests they are co-
regulated. A key mediator of this co-regulation is PU.1, whose
expression declines at the transition from S0 to S1. We have
identified a novel cross-antagonism between S-phase progression
and PU.1 expression. We show that S-phase arrest, caused by high
levels of p57KIP2 or by cell cycle blocking drugs, prevents
downregulation of PU.1 (Figure 3E,H); conversely, failure to
downregulate PU.1 arrests S-phase progression (Figure 4B,C).
Either maneuver blocks erythroid differentiation, including a block
of chromatin reconfiguration at the b-globin locus and blocked
expression of erythroid-specific genes (Figures 3B, 3D–H, S3G,
S3I, 4B, 5E, 6C–D).
We propose that the mutual inhibition between PU.1 and S-
phase progression at the S0 to S1 transition (Figure 7B)
simultaneously controls the transition in both differentiation and
cell cycle states. Its function is analogous to a synchromesh
mechanism in automotive transmission, matching the speeds of
two rotating gears before allowing them to lock together during a
gear-shift. The mutual antagonism between S-phase progression
and PU.1 expression ensures that PU.1 downregulation does not
occur prior to the cell’s entry into S-phase; conversely, S-phase
entry cannot occur before conditions for PU.1 downregulation are
in place. In this manner the cell cycle and differentiation programs
can only proceed when precisely synchronized.
Once cells have transitioned from S0 into S1, S-phase
progression is no longer required for expression of erythroid genes
(Figure 3C, Figure S3E–F). Therefore, the synchromesh mecha-
nism is specific to the transition from S0 to S1, when committal
decisions bring about an irreversible terminal differentiation
phase. Our findings reveal a key organizational feature in
erythroid differentiation and have implications for differentiation
of other lineages, where similar synchronization events may occur.
Further, the synchromesh mechanism we describe may be a target
in leukemogenesis, consistent with reports that high levels of PU.1
promote erythroleukemia [15]. Similarly, although no reports at
present implicate p57KIP2 specifically in erythropoiesis, mutations
in p57KIP2 are implicated in the familial Beckwith-Weidemann
syndrome, which predisposes to pediatric tumors [22].
The Cross-Antagonism between PU.1 and S-Phase
Progression Is Lineage and Differentiation Stage-Specific
PU.1, whose physiological function in erythropoiesis had not
been clear, plays a pivotal role at the S0 to S1 transition, through
its cross-antagonism with S-phase progression. This cross-antag-
onism is lineage and differentiation stage-specific, since it
presumably does not operate in myeloid and B-cell lineages where
PU.1 is an essential transcriptional activator. Similarly, within the
erythroid lineage, this mutual antagonism must be activated
specifically in the last generation of CFU-e. Its premature
activation at an earlier CFU-e cycle may be predicted to result
in premature transition into S1 and consequently, in a reduced
number of differentiated progeny. This prediction helps explain
previous observations, where erythroid cells from PU.1-null
embryos were found to differentiate prematurely and to have
reduced self-renewal capacity [36]. These observations are
consistent with the PU.1-null phenotype mimicking premature
downregulation of PU.1. The mutual inhibition between PU.1 and
S-phase may also explain findings in the T-cell lineage, where
exogenous expression of PU.1 at the pro-T cell stage was found to
block both thymocyte expansion and differentiation [37].
The Cross-Antagonism between PU.1 and GATA-1
Previous work documented cross-antagonism between PU.1 and
GATA-1, showing them to interfere with each other’s transcrip-
tional functions through a variety of mechanisms including direct
physical binding [11–14]. We propose that the activation of
erythroid terminal differentiation at the S0/S1 boundary is due to
functional activation of GATA-1 (Figure 7B). Though present in
S0 cells prior to the transition into S1 (Figure 3A), GATA-1
function is inhibited by PU.1. Downregulation of PU.1 at the S0 to
S1 transition alleviates this inhibition, allowing GATA-1-mediated
activation of erythroid gene induction. Among its known targets,
GATA-1-mediated transcriptional repression of GATA-2 [29]
would account for our observation that GATA-2 is downregulated
at the S0 to S1 transition (Figure 3A). This scheme places the
decrease in GATA-2 downstream of the cross-antagonism
between PU.1 and GATA-1 (Figure 7B) and explains why
exogenous high levels of GATA-2, unlike PU.1, do not block the
transition from S0 to S1 (Figure 4).
Based largely on immortalized progenitor-like cells, the
antagonism between GATA-1 and PU.1 was proposed to underlie
a binary cell fate choice in cells expressing both GATA factors and
PU.1. An increase in GATA-1 would result in PU.1 suppression
and the erythro-megakaryocytic cell fates, whereas an increase in
PU.1 would suppress GATA-1 and give rise to the myelo-
lymphocytic lineages [11–14]. However, our data show that CFU-
e cells, considered committed erythroid progenitors, express PU.1
at levels equivalent with those found in cells of the myeloid lineage
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Figure 7. Regulatory events at the transition from S0 to S1. (A) Multiple differentiation milestones coincide with early S-phase in the last CFU-e
generation. Upregulation of CD71 marks the transition from S0 to S1 in early S-phase of this cell cycle. It coincides with the onset of Epo dependence,
downregulation of transcriptional suppressor PU.1 and CDKI p57KIP2, and reconfiguration of chromatin at the b-globin locus, including a switch in the
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(Figure S3A). Our results are consistent with previous reports of
PU.1 expression in early erythroid progenitors, including the
expression of a GFP reporter ‘‘knocked in’’ to the PU.1 gene locus
in S0 (CD71lowTer119negative) fetal liver cells [36,38].
The biochemical nature of commitment to the erythroid lineage
is unknown at present. It is possible that CFU-e cells prior to PU.1
downregulation, which are also expressing GATA-1 and GATA-2,
are in fact multipotential cells that may give rise to either myeloid
or erythro-megakaryocytic lineages. In this case, the cross-
antagonism between PU.1 and GATA-1 would simultaneously
be responsible for a lineage choice, as well as facilitate activation of
the erythroid gene expression program at the S0 to S1 transition
should this choice be in favor of the erythroid lineage. Our ability
to isolate CFU-e cells expressing high levels of PU.1 prior to their
transition into S1 should facilitate further study of this issue.
The Role of S-Phase
Why is S-phase progression coupled to the erythroid differen-
tiation program at the S0 to S1 boundary? Linking developmental
transitions to cell cycle phases may serve as a strategy for their
correct developmental timing [39] and may ensure the correct
number of differentiated progeny. Another possibility is that S-
phase progression plays a direct role in the re-configuration of
chromatin at erythroid-specific gene loci. DNA replication was
proposed to provide an opportunity for structural changes in
chromatin, since the passage of the replication fork transiently
disrupts nucleosomes [4,5]. Indeed, S-phase is essential for
activation or silencing of some genes in yeast [40,41] and metazoa
[39,42–45], though it is not known that this is due to a
requirement in the reconfiguration of chromatin. However, S-
phase is not required for activation of other developmental genes
[46–50]. Further, in recent years the structure of chromatin was
found to be much more dynamic outside S-phase than originally
suspected [51]. It is therefore unclear whether there is an innate
requirement for DNA replication in the reconfiguration of
chromatin during activation of lineage-specific genes, or what
specific aspects of chromatin restructuring might require S-phase.
Here we found that S-phase is required for DNA demethylation
and for formation of DNase I hypersensitive sites. The
requirement for DNA replication suggests that DNA demethyla-
tion is passive, due to a decrease in maintenance methylation of
the nascent DNA strand [52]. This raises the possibility that
formation of DNase I hypersensitive sites may require DNA
replication because it might be contingent on DNA demethylation.
Alternatively, DNase I hypersensitivity may require S-phase
progression in order to lift a direct repressive effect of PU.1 on
chromatin [13].
The Role of EpoR
Our examination of EpoR2/2 fetal liver shows that the EpoR
becomes essential for erythroid differentiation at the S0/S1
boundary. The principal function of EpoR at this time is its pro-
survival signaling: EpoR2/2 erythroid progenitors undergo
apoptosis but their cell cycle status is unaltered, suggesting that
EpoR signaling is not required for S-phase progression (Figure
S1E). These findings are consistent with the established role of
EpoR as a survival factor that does not affect the erythroid cell
cycle [53]. EpoR signaling is probably also dispensable for
downregulation of PU.1 at the S0 to S1 transition, since both
PU.1 and GATA-2 are low in EpoR2/2 cells (Figure 3A).
In spite of both S-phase progression and PU.1 downregulation
being apparently unimpaired, EpoR2/2 cells fail to develop
DNase I HS sites and fail to undergo DNA demethylation at the b-
globin LCR (Figures 5D, 6A). It has been reported that exogenous
expression of bcl-xL facilitates Epo-independent differentiation of
erythroblasts [54] arguing against a direct requirement for EpoR
signaling in chromatin reconfiguration. Therefore, EpoR2/2 cells
may be undergoing rapid apoptosis prior to the time when the
chromatin change would have otherwise taken place.
Other than its survival function, EpoR is probably directly
required for CD71 upregulation, via Stat5 [55,56]. However,
EpoR signaling results in CD71 upregulation only if S-phase is
allowed to proceed (Figure 2).
Thus, while the onset of Epo dependence occurs synchronously
with committal chromatin and transcriptional events in erythroid
differentiation, there is apparently no direct requirement for EpoR
signaling in these events, other than ensuring cell survival. The
principal function of Epo in erythropoiesis is to determine the
number of differentiated erythrocytes, via Epo concentration [57].
The S0 to S1 transition may have evolved as the time of onset of
Epo dependence as it represents a biochemical commitment to
erythroid differentiation, setting in motion chromatin and
transcriptional transformations that lead to expression of ery-
throid-specific genes. This therefore represents the earliest time in
erythroid differentiation when Epo may regulate cell number
specifically within the erythroid lineage, with minimal lateral
effects on other hematopoietic cells.
An All-or-None Switch in Chromatin State at the b-Globin
LCR
The b-globin LCR had long been studied as a model of
chromatin at sites of lineage-specific genes. However, the time in
erythroid differentiation when the locus switches from a ‘‘closed’’
to an ‘‘open’’ conformation had not been clearly defined. Further,
it was not known whether activation of the locus develops in a
step-wise fashion over several cell cycles and differentiation stages
or whether it occurs rapidly in a single step.
Our findings show that, strikingly, the locus transitions to an
active conformation rapidly, within S-phase of a single cell cycle.
Further, several distinct functional and biochemical changes that
characterize the active chromatin conformation appear to develop
simultaneously. We found marked differences between S0 and S1
cells in DNA methylation and in DNase I hypersensitivity at the
LCR. These transformations could be reproduced when purified
S0 cells transitioned into S1 in vitro (Figures 5, 6). Both DNA
demethylation and DNase I hypersensitivity required S-phase
timing of replication from late to early S-phase and, within the LCR, the formation of DNase I hypersensitivity sites, the onset of DNA demethylation,
and a loss of repressive histone marks from bivalent chromatin. The dashed black line marks the time at which inhibition of S-phase arrests PU.1
downregulation, CD71 upregulation, and the switch in chromatin. Induction of erythroid transcriptional activators, including GATA-1, precedes this
step. Erythroid specific genes including b-globin, Band3, and ALAS2 are induced subsequently. Upregulation of Ter119 occurs approximately with
entry into the next cell cycle. (B) Causal relationships at the transition from S0 to S1. Red arrows mark novel causal relationships implicated in the
transition from S0 to S1. Downregulation of p57KIP2 is required for S-phase progression during the last CFU-e generation. Mutual antagonism
between PU.1 and S-phase results in PU.1 downregulation as cells progress into S-phase. Decreasing PU.1 allows for functional activation of GATA-1,
which in turn represses GATA-2 and induces erythroid-specific genes such as b-globin. S-phase progression is also required for the formation of
DNase I hypersensitive sites and for DNA demethylation bringing about a switch in chromatin conformation at the b-globin LCR and, together with
Epo, for CD71 upregulation.
doi:10.1371/journal.pbio.1000484.g007
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progression for their development. Further, we also found that
development of histone-tail modifications characteristic of active
chromatin, as well as the switch in the timing of replication of the
locus from late to early S-phase, both coincide with the transition
from S0 to S1 (Figure 5). Therefore, our findings support an ‘‘all or
none’’ model for the state of chromatin, previously hypothesized
based on the probabilistic nature of developing DNase I
hypersensitivity in a range of mutated chicken b-globin enhancer
constructs [58].
Previous work showed that while the highest levels of DNase I
accessibility at the b-globin LCR are attained in mature erythroid
progenitors, the b-globin LCR is already poised for expression in
earlier multipotential progenitors, contributing to low-level b-
globin transcription (‘‘priming’’) [59,60]. The b-globin LCR was
found to already contain DNase I hypersensitive sites in cell lines
resembling early hematopoietic progenitors [61]. Here we find
that the b-globin LCR appears poised for change prior to the
transition from S0 to S1. Thus, LSK and S0 cells have similar
DNA methylation levels that are substantially lower than in fetal
brain, suggesting chromatin already primed for expression at the
LSK stage (Figure 6A). Histone tail modifications in the LCR
similarly suggest that chromatin in S0 is poised for change, as it is
enriched with both H3K4me2, a mark associated with active
chromatin, and with H3K27me3, a mark found in silent
chromatin (Figure 5G). The LCR is therefore marked as a
bivalent domain, which may denote chromatin that is silent but
primed for activation [62,63]. Regardless of the precise state of
chromatin readiness in earlier hematopoietic progenitors, howev-
er, our results show a clear switch in chromatin conformation at
the S0 to S1 transition.
The clear switch we identified at the b-globin LCR occurs in
synchrony with other switch-like transformations at the transition
from S0 to S1, including the onset of Epo dependence and
activation of GATA-1 function. Our ability to identify this
transition with precision in vivo and manipulate it genetically in
vitro should facilitate further study of the pivotal link between the
cell cycle clock and the committal chromatin decisions that bring
about the erythroid phenotype.
Materials and Methods
Flow Cytometry
Fetal livers (E12.5–E14) were mechanically dissociated and
immunostained as described [64]. Immunofluorescence was
measured on an LSRII (BD Biosciences, CA) and data analyzed
using FloJo (Tree Star, CA). Cells were sorted on a FACSAria,
FACSVantage (BD Biosciences), or MoFlo (Beckman Coulter) cell
sorters. In a small number of experiments StemSep columns
(StemCell Technologies) were used.
In Vitro Culture
Freshly harvested fetal liver cells were sorted and cultured in
medium containing 20% fetal calf serum and 2 U/ml Epo
(Amgen) for up to 48 h.
Cell Cycle Analysis
BrdU (100 ml of 10 mg/ml) was injected intra-peritonealy to
pregnant mice and embryos were harvested 30–50 min later. In
vitro, cells were pulsed with BrdU for 30 min. BrdU incorporation
was detected using BrdU flow kit (BD Biosciences). Cell tracking
with CFSE (carboxyfluorescein diacetate succinimidyl ester) was
performed on sorted S0, incubated with 2.5 mM CFSE (Invitro-
gen) for 10 min at 37uC.
Retroviral Transduction
Retroviral transduction was by spin infection of sorted S0 cells
at 2,000 rpm, 37uC on fibronectin coated dishes in 5 mg/ml
polybrene (Sigma). Transduced cells were incubated overnight in
the presence of 100 ng/ml SCF and 10 ng/ml IL3 (Peprotech,
Rocky Hill, NJ) and were then transferred to Epo-containing
medium for the indicated times.
Quantitative RT-PCR
Quantitative RT-PCR was performed as described [64].
DNase I Hypersensitivity Assays
DNase I hypersensitivity assays were performed as described
[34] with modifications to amplicons (see Supplemental Methods).
ChIP-qPCR
ChIP-qPCR was performed on 106 cells/sample of sorted S0,
sorted S1, or fetal brain. Cells were cross-linked in 1%
formaldehyde, sonicated, and incubated overnight with a range
of antibodies (see Supplemental Data), followed by 3–4 h of
incubation with Protein G-magnetic beads (Invitrogen). Cross-
links were reversed and purified DNA measured by qPCR using
the same amplicons as in the DNase I hypersensitivity assay.
DNA Methylation
Genomic DNA or cells were treated with sodium bisulfite
(Zymo Research, Orange, CA). Bisulfite-converted DNA was
amplified by PCR and methylation levels measured using
pyrosequencing at EpigenDx (Worcester, MA).
See Text S1 for additional methods, primer sequences, and
antibodies.
Supporting Information
Figure S1 Supplemental data to Figure 1. (A) Ter119+ cells
in EpoR2/2 fetal livers are nucleated erythrocytes of the yolk-sac
(primitive) lineage. Cytospin preparations of sorted Ter119+ cells
from fetal livers of EpoR2/2 (E12.5) and wild-type littermate.
Yolk-sac erythrocytes are fully hemoglobinized, large nucleated
cells (arrow; see brown coloration of hemoglobinized cells stained
with diaminobenzidine). Basophilic (blue cytoplasm) erythroblast
precursors of the definitive lineage form the majority of Ter119+
cells in the wild type fetal liver but are absent from EpoR2/2 fetal
liver. Scale bar = 20 m. (B) Distribution of cells expressing non-
erythroid lineage markers within fetal liver. The fraction of cells
expressing each indicated marker is shown for embryonic ages
E12.5 to E14.5 in wild-type embryos, and for EpoR2/2 embryos
on E12.5. The same data are represented for each lineage marker
either as a fraction of whole fetal liver (left panel) or as a fraction of
S0 (right panel). (C) The fraction of S0 cells expressing EpoR
mRNA assessed by single cell RT-PCR. Single cell RT-PCR was
carried out on 324 individual S0 cells. An mRNA signal (either
EpoR or b-actin or both) was obtained for 159 cells (49%). 68% of
cells with a positive mRNA signal were positive for the EpoR
mRNA. Single S0 cells were sorted by flow-cytometry into single
wells of a 96-well plate. Following reverse transcription, two
rounds of PCR amplification were used to detect EpoR and b-
actin expression in individual cells. Shown are representative
examples of RT-PCR for EpoR (top gel) and b-actin (lower gel) for
four individual cells (lanes 1 to 4). The cells in lanes 1 and 4
expressed both EpoR and b-actin. Neither EpoR nor b-actin
signals were obtained for the cell in lane 3. The cell in lane 2
expressed only b-actin. Control lanes are RT-PCR on spleen cells
(positive control, ‘‘c1’’), thigh muscle (negative control, ‘‘c2’’), and
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no template (negative control, ‘‘c3’’). (D) BrdU incorporation rate
(measured as median fluorescence intensity, MFI) in wild-type S1
is higher than in other fetal liver subsets, and higher than in
EpoR2/2 fetal liver (latter computed for the few cells within the
S1 gate). Difference between wild-type S0 and S1 is significant at
p,0.0001 (paired t test). Data are mean 6 SE of 7 independent
experiments. (E) Left panels: EpoR does not regulate cell cycle
status of erythroid progenitors. Representative CD71/Ter119
profiles (upper panels) and BrdU/7AAD (lower panel) for the S0
subset in EpoR2/2 fetal liver and in wild-type littermates. The
fractions (%) of S-phase cells (lower panels) is indicated. Right
panel: EpoR regulates survival of erythroid progenitors. ‘‘LIVE/
DEAD’’ profiles of the same EpoR2/2 and wild-type littermate
embryos. The LIVE/DEAD dye (Molecular Probes) stains
apoptotic cells with impaired membrane permeability prior to
fixation and permeabilization assays. The fractions (%) of
apoptotic cells are indicated. (F) qRT-PCR analysis of mRNA
expression for p27KIP1, p21CIP1, and p57KIP2 in sorted fetal liver
subsets S0 to S3 cells. Data were normalized to the b-actin mRNA
in each sample and expressed as a ratio to the S0 subset. Data are
mean 6 SD of three independent experiments.
Found at: doi:10.1371/journal.pbio.1000484.s001 (0.90 MB TIF)
Figure S2 Supplemental data to Figure 2. (A) S1 cells are
sensitive to hydroxyurea (HU). S0 cells were sorted by flow-
cytometry (t = 0) and incubated in the presence or absence of Epo,
and in the presence or absence of HU (5 mM), as indicated.
Samples incubated in Epo alone upregulated CD71 and Ter119
sequentially (see t = 15 h, t = 24 h). Upregulation of CD71, but not
Ter119, is Epo dependent (see ‘‘no Epo’’ sample in which Epo was
added at t = 15 h). Cells incubated in Epo and HU did not
upregulate CD71 or Ter119, consistent with the transition into S1
(CD71 upregulation) being S-phase dependent. Cells incubated in
Epo alone for 15 h had transitioned into S1 and began to
transition into S2. If HU was added at this point (t = 15 h), nearly
all S1 cells are lost (due to HU toxicity, unpublished data), but
many cells in S0 and S2 persist. This suggests that essentially all S1
cells are in S-phase. (B) Preventing CD71 upregulation at the S0/
S1 boundary does not interfere with the erythroid cell cycle.
Sorted S0 cells were transduced with retroviral vectors containing
an ‘‘IRES-GFP’’ reporter, expressing short hairpin RNA targeting
CD71 (CD71shRNA) or ‘‘empty vector’’ control (LMPv). Cells
were then cultured for 24 h in the presence of Epo. Shown are the
CD71/Ter119 profiles (top panels) and corresponding BrdU/
7AAD cell cycle profiles of cells at t = 24 h. Only retrovirally
infected cells are shown, identified by the expression of GFP. The
fraction (%) of cells in each gate is indicated. Representative of
three experiments. (C) Cytospin preparations of cells in the
experiment described in (B) at t = 24 h. Control cells, but not cells
expressing shRNA to CD71, have started to express hemoglobin in
their cytoplasm (brownish color, see arrow). Stained with Giemsa-
diaminobenzidine; scale bar is 20 m.
Found at: doi:10.1371/journal.pbio.1000484.s002 (1.38 MB
DOC)
Figure S3 Supplemental data to Figure 3. (A) Quantitative
RT-PCR analysis of PU.1, Gata-2, and Gata-1 mRNAs in Mac-
1+, S0, or S1 cells sorted from fetal liver. mRNAs were normalized
to the b-actin mRNA in each sample. Data are mean 6 SD of 2
independent experiments. (B) Total RNA per cell in sorted fetal
liver subsets. Total isolated RNA for each subset was measured
using spectrophotometric optical density and divided by the
number of sorted cells. Mean 6 SE of five independent sort
experiments. (C) Flow-cytometry histograms of PU.1 protein levels
in sorted fetal liver subsets S0 to S3. Fresh fetal liver cells were
fixed, permeabilized, and stained for CD71, Ter119, and PU.1.
Bar graph indicates the PU.1 median fluorescence intensity of
each subset. Representative of 2 independent experiments. (D)
EpoR mRNA increases at the S0 to S1 transition. Results
normalized to b-actin and expressed as a ratio to S0. (E,F)
Experimental design for (E) and (F): sorted S1 cells (t = 0 h) were
incubated in Epo and in the presence or absence of aphidicolin,
for 10 h. Cells were then washed free of aphidicolin and Epo
incubation continued for a further 10 h. (E) Arrest of S-phase
progression in S1 does not affect the mRNA expression of
erythroid-specific genes, b-globin, Alas2, and Band3. mRNA was
measured by qRT-PCR, normalized to b-actin, and expressed as
relative to mRNA at t = 0. Data are mean 6 s.e.m. from 3
independent experiments. (F) Arrest of S-phase progression in S1
does not affect expression of Ter119. CD71/Ter119 profiles
showing that Ter119 was upregulated between t = 0 and t = 10 h
regardless of the presence of aphidicolin. The fraction (%) of cells
in S1 (left gate) or S2 (right gate) is indicated. Note that the larger
cell size resulting from aphidicolin-mediated block of DNA
replication (Figure 3F, main manuscript) is likely responsible for
the higher Ter119 signal in the aphidicolin treated cells (cell
surface Ter119 would be expected to increase in proportion to the
square of the cell’s radius). Ten hours following the release of the
block, there is no significant difference in Ter119 expression
between treated and untreated cell samples (t = 20 h). (G) Effect of
mimosine-mediated S-phase arrest on downregulation of PU.1
and Gata-2 during the S0 to S1 transition. Experiment and
mRNA measurement were as in Figure 3D, main manuscript, with
the exception that mimosine was used in place of aphidicolin. Data
are mean 6 SE of three independent experiments. (H) Effect of
aphidicolin-mediated S-phase arrest on Lmo2 and Nfe2 mRNAs
during the S0 to S1 transition. Experiment and mRNA
measurements as in Figure 3B, main manuscript; mRNA levels
are expressed as a ratio to mRNA at t = 10 h in the ‘‘Epo only’’
control. Data are from two independent experiments. (I)
Erythroblast morphology of S0 cells transduced with p57T329A-
ICD4 or with control vector MICD4 at t = 32 h of incubation in
Epo. Experiment as described in Figure 3G, main manuscript.
Cytospins were stained with Giemsa-diaminobenzidine; scale
bar = 20 m.
Found at: doi:10.1371/journal.pbio.1000484.s003 (0.66 MB
DOC)
Figure S4 Supplemental data to Figure 4. (A–B) PU.1
protein levels in cells transduced with PU.1-IRES-hCD4 is
proportional to the level of the hCD4 reporter in the same cells.
Please see also summary of these data in Figure 4D. (A) Expression
profiles of the hCD4 reporter in cells transduced with either PU.1-
ICD4, or MICD4 control vector, or uninfected control cells,
following 24 h of culture in Epo. Vertical, narrow gates each
containing cells of relatively uniform hCD4 expression, numbered
1 to 4, are shown and are used in the analysis in sections (B) and in
Figure 4D. (B) Flow-cytometry histograms of cells transduced with
MICD4 control vector (top panels) or with PU.1-ICD4 (lower
panels) for each individual hCD4 gate (numbered 1 to 4), showing
the percent of PU.1 positive cells. An overlay of the same flow-
cytometry histograms is shown on the right. (C) Expression of
GATA-1-IRES-hCD4 (GATA-1-ICD4), GATA-2-ICD4, and
MICD4 at 24 h of Epo culture. The hCD4+ cell gate is indicated
in black. Associated with Figure 4E in the main text. (D) qRT-
PCR analysis of Gata-1, Gata-2, and PU.1 mRNAs in S0 cells
transduced with MICD4 control vector or gene-ICD4 at 24 h of
Epo culture, as compared with endogenous levels in freshly sorted
S0 and S1 subsets. mRNA was normalized to the b-actin mRNA
and expressed as a ratio to the S0 subset. Data are mean 6 SD of
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3 independent experiments (the transduction efficiency was .90%
for PU.1-ICD4 and .50% for Gata-1-ICD4 and Gata-2-ICD4).
(E) Preventing downregulation of PU.1 does not halt downregu-
lation of p57KIP2 mRNA. Quantitative RT-PCR analysis of
p57KIP2 mRNA in S0 cells retrovirally transduced with PU.1-
ICD4 or with control vector MICD4 as described in Figure 4A–C,
and incubated for 24 h in Epo. mRNA measurements from two
independent experiments. In the first experiment, hCD4-positive
cells were sorted by flow-cytometry at t = 0 (first experiment). In
the second experiment transduction efficiency exceeded 90%, as
judged by hCD4 expression. mRNAs were also measured in
freshly sorted S0 and S1 subsets.
Found at: doi:10.1371/journal.pbio.1000484.s004 (0.55 MB
DOC)
Text S1 Supporting materials and methods. Additional
methods, primer sequences, and details of antibodies used.
Found at: doi:10.1371/journal.pbio.1000484.s005 (0.14 MB
DOC)
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